Organization (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) segment product	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of commercial-stage products | product	3
Number of reportable segments | segment	1
Accumulated deficit	$ 407,039		$ 403,177
Net loss	3,862	$ 7,495
Cash and cash equivalents	62,938	$ 61,834	$ 69,088
Short term investments	$ 77,100